Direkt zum Inhalt
Merck
  • FPIN's clinical inquiries: Antidepressants for the treatment of insomnia in patients with depression.

FPIN's clinical inquiries: Antidepressants for the treatment of insomnia in patients with depression.

American family physician (2011-12-15)
Molly S Clark, Patrick O Smith, Barbara Jamieson
MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
Trazodon -hydrochlorid, ≥99% (HPLC), powder
Sigma-Aldrich
Doxepin -hydrochlorid, ~85% E-isomer basis, ≥98% (GC), 15% Z-isomer basis, powder
Supelco
Trazodone hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
Supelco
Doxepin hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material, Cerilliant®
Sigma-Aldrich
Trimipramin -maleat (Salz), ≥98% (TLC), powder
Doxepin für die Systemeignung, European Pharmacopoeia (EP) Reference Standard